CIK 0001299130 · Accelerated filer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Sign in to watch- Ticker
- PACB
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161590339
- Phone
- 650-521-8000
- Business address
- 1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025
- Former names
- PACIFIC BIOSCIENCES OF CALIFORNIA INC, NANOFLUIDICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,087,330
- in 2 filings, $2.1M under 10b5-1 plans
Net −$2,087,330. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-15 | Phillips James Michael SVP, Research & Development | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2017-11-24 | CORCORAN KEVIN P SVP, Market Development | Option exercise | +256 | $1.96 | $502 | 158,174 |
| 2017-11-24 | CORCORAN KEVIN P SVP, Market Development | Option exercise · Stock Option (right to buy) | −256 | 0 | ||
| 2017-11-15 | ORDONEZ KATHY Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +375,000 | 375,000 | ||
| 2017-07-20 | CORCORAN KEVIN P SVP, Market Development | Option exercise | +28,061 | $1.96 | $55K | 156,313 |
| 2017-07-20 | CORCORAN KEVIN P SVP, Market Development | Option exercise · Stock Option (right to buy) | −28,061 | 256 | ||
| 2017-06-14 | CORCORAN KEVIN P SVP, Market Development | Option exercise | +84,183 | $1.96 | $165K | 128,252 |
| 2017-06-14 | CORCORAN KEVIN P SVP, Market Development | Option exercise · Stock Option (right to buy) | −84,183 | 28,317 | ||
| 2017-06-02 | BARNES SUSAN K EVP, CFO and PAO | Option exercise | +276,238 | $2.27 | $627K | 347,417 |
| 2017-06-02 | BARNES SUSAN K EVP, CFO and PAO | Option exercise · Stock Option (right to buy) | −276,238 | 48,762 | ||
| 2017-06-01 | Hunkapiller Michael Chairman, CEO & President | Option exercise | +500,000 | $3.01 | $1.5M | 2,300,000 |
| 2017-06-01 | Hunkapiller Michael Chairman, CEO & President | Option exercise · Stock Option (right to buy) | −500,000 | 500,000 | ||
| 2017-05-24 | MILLIGAN JOHN F Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2017-05-24 | LIVINGSTON RANDALL S Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2017-05-24 | Shapiro Lucy Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2017-05-24 | ORDONEZ KATHY Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2017-05-24 | MOHR MARSHALL Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2017-05-24 | Ericson William W. Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2017-05-24 | Botstein David Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2017-02-15 | CORCORAN KEVIN P SVP, Market Development | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 |
Page 23 of 29 · 561 trades